These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 20600435)

  • 1. Neurochemical changes in a double transgenic mouse model of Alzheimer's disease fed a pro-oxidant diet.
    Ash ES; Alavijeh MS; Palmer AM; Mitchelmore C; Howlett DR; Francis PT; Broadstock M; Richardson JC
    Neurochem Int; 2010 Nov; 57(5):504-11. PubMed ID: 20600435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pro-oxidant diet enhances β/γ secretase-mediated APP processing in APP/PS1 transgenic mice.
    Choudhry F; Howlett DR; Richardson JC; Francis PT; Williams RJ
    Neurobiol Aging; 2012 May; 33(5):960-8. PubMed ID: 20724034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of cholinergic markers, biogenic amines, and amino acids in the CNS of two APP overexpression mouse models.
    Van Dam D; Marescau B; Engelborghs S; Cremers T; Mulder J; Staufenbiel M; De Deyn PP
    Neurochem Int; 2005 Apr; 46(5):409-22. PubMed ID: 15737439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes.
    Howlett DR; Richardson JC; Austin A; Parsons AA; Bate ST; Davies DC; Gonzalez MI
    Brain Res; 2004 Aug; 1017(1-2):130-6. PubMed ID: 15261108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated administration of the noradrenergic neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) modulates neuroinflammation and amyloid plaque load in mice bearing amyloid precursor protein and presenilin-1 mutant transgenes.
    Pugh PL; Vidgeon-Hart MP; Ashmeade T; Culbert AA; Seymour Z; Perren MJ; Joyce F; Bate ST; Babin A; Virley DJ; Richardson JC; Upton N; Sunter D
    J Neuroinflammation; 2007 Feb; 4():8. PubMed ID: 17324270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repeated novel cage exposure-induced improvement of early Alzheimer's-like cognitive and amyloid changes in TASTPM mice is unrelated to changes in brain endocannabinoids levels.
    Pardon MC; Sarmad S; Rattray I; Bates TE; Scullion GA; Marsden CA; Barrett DA; Lowe J; Kendall DA
    Neurobiol Aging; 2009 Jul; 30(7):1099-113. PubMed ID: 18023506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice.
    Arendash GW; Jensen MT; Salem N; Hussein N; Cracchiolo J; Dickson A; Leighty R; Potter H
    Neuroscience; 2007 Oct; 149(2):286-302. PubMed ID: 17904756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-cognitive behaviours in an APP/PS1 transgenic model of Alzheimer's disease.
    Pugh PL; Richardson JC; Bate ST; Upton N; Sunter D
    Behav Brain Res; 2007 Mar; 178(1):18-28. PubMed ID: 17229472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
    Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
    Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress status and RNA expression in hippocampus of an animal model of Alzheimer's disease after chronic exposure to aluminum.
    Garcia T; Esparza JL; Nogués MR; Romeu M; Domingo JL; Gómez M
    Hippocampus; 2010 Jan; 20(1):218-25. PubMed ID: 19405147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human apoB overexpression and a high-cholesterol diet differently modify the brain APP metabolism in the transgenic mouse model of atherosclerosis.
    Bjelik A; Bereczki E; Gonda S; Juhász A; Rimanóczy A; Zana M; Csont T; Pákáski M; Boda K; Ferdinandy P; Dux L; Janka Z; Sántha M; Kálmán J
    Neurochem Int; 2006 Sep; 49(4):393-400. PubMed ID: 16546298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of aging and Alzheimer's disease-like pathology on brain monoamines in mice.
    Von Linstow CU; Severino M; Metaxas A; Waider J; Babcock AA; Lesch KP; Gramsbergen JB; Finsen B
    Neurochem Int; 2017 Sep; 108():238-245. PubMed ID: 28414094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calpastatin levels affect calpain activation and calpain proteolytic activity in APP transgenic mouse model of Alzheimer's disease.
    Vaisid T; Kosower NS; Katzav A; Chapman J; Barnoy S
    Neurochem Int; 2007; 51(6-7):391-7. PubMed ID: 17513017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.
    Poduslo JF; Curran GL; Wengenack TM; Malester B; Duff K
    Neurobiol Dis; 2001 Aug; 8(4):555-67. PubMed ID: 11493021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aluminum exposure through the diet: metal levels in AbetaPP transgenic mice, a model for Alzheimer's disease.
    Gómez M; Esparza JL; Cabré M; García T; Domingo JL
    Toxicology; 2008 Jul; 249(2-3):214-9. PubMed ID: 18571827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
    Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
    Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The occurrence of a deficit in contextual fear extinction in adult amyloid-over-expressing TASTPM mice is independent of the strength of conditioning but can be prevented by mild novel cage stress.
    Rattray I; Scullion GA; Soulby A; Kendall DA; Pardon MC
    Behav Brain Res; 2009 Jun; 200(1):83-90. PubMed ID: 19162086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
    Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
    J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APP intracellular domain is increased and soluble Abeta is reduced with diet-induced hypercholesterolemia in a transgenic mouse model of Alzheimer disease.
    George AJ; Holsinger RM; McLean CA; Laughton KM; Beyreuther K; Evin G; Masters CL; Li QX
    Neurobiol Dis; 2004 Jun; 16(1):124-32. PubMed ID: 15207269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and neurochemical characterization of mice deficient in the phosphodiesterase-1B (PDE1B) enzyme.
    Siuciak JA; McCarthy SA; Chapin DS; Reed TM; Vorhees CV; Repaske DR
    Neuropharmacology; 2007 Jul; 53(1):113-24. PubMed ID: 17559891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.